PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-11-07

Date Title Company
07-Nov-2019 Epigenomics AG successfully completes capital increase Epigenomics AG
07-Nov-2019 Therapix Biosciences and Destiny Biosciences Global Corp. Mutually Decide to Discontinue Negotiations on Planned Merger Therapix Biosciences Ltd.
07-Nov-2019 TrialScope Announces Winners of 2nd Annual Clārus Awards at Clinical Trial Transparency Conference TrialScope
07-Nov-2019 Actinium Pharmaceuticals to Present at the 25th Annual BIO-Europe® 2019 International Partnering Conference Actinium Pharmaceuticals, Inc.
07-Nov-2019 Penumbra, Inc. Reports Third Quarter 2019 Financial Results Penumbra, Inc.
07-Nov-2019 Eiger BioPharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Business Update Eiger BioPharmaceuticals, Inc.
07-Nov-2019 Immunic, Inc. Reports Third Quarter 2019 Financial Results and Highlights Recent Activity Immunic, Inc.
07-Nov-2019 MOLOGEN AG: Focusing on combination therapies MOLOGEN AG
07-Nov-2019 Signant Health Host 8th Annual eCOA Forum To Convene Clinical Operations and Outcomes Research Leaders Guiding the Future of Patient-Centric Technology Signant Health
07-Nov-2019 EUROPEAN SPACE AGENCY AWARDS CONTRACT TO SPIRIT DIGITAL TO DEVELOP A SATELLITE ENABLED, DIGITALLY CONNECTED HEALTHCARE PLATFORM Spirit Digital
07-Nov-2019 Delaware and North East England Sign Economic Development MOU Delaware Prosperity Partnership
07-Nov-2019 Combatting Counterfeiters Neo PR Limited
07-Nov-2019 TrialAssure Launches First-in-Class Document Anonymization Tool Using Machine Learning and Artificial Intelligence to Protect Patient Data TrialAssure
07-Nov-2019 Signant Health Proud to Sponsor the Philadelphia Walk to End Alzheimer’s in Nationwide Effort to Build Awareness, Raise Funds and Advance Research Towards a Cure. Signant Health
07-Nov-2019 RHÖN-KLINIKUM AG: Supervisory Board Approves to Establish Medgate Deutschland GmbH RHÖN-KLINIKUM AG
07-Nov-2019 Secarna Pharmaceuticals to Attend International Partnering and Investor Conferences in November Secarna Pharmaceuticals GmbH & Co. KG
07-Nov-2019 Artios Pharma, MD Anderson and ShangPharma announce in-licensing agreement for DNA damage response inhibitor Artios Pharma Limited
07-Nov-2019 Urania Therapeutics closes a €3.5M initial seed round Advent France Biotechnology
07-Nov-2019 Freeline to present data on AAV-based gene therapies for Gaucher Disease and Haemophilia A at the 61st ASH Annual Meeting Freeline
07-Nov-2019 Recent Advances in Bavarian Nordic’s Cancer Immunotherapy Platform Published in Nature Communications Bavarian Nordic